BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10330998)

  • 1. Induction of tolerance by oral administration of a tolerogenic allochimeric donor/recipient class I MHC protein.
    Stepkowski SM; Yu J; Wang M; Kahan BD
    Transplant Proc; 1999 May; 31(3):1557. PubMed ID: 10330998
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of donor-specific tolerance by chimeric class I MHC molecules bearing donor alpha 1 helical amino acids.
    Wang M; Yu J; Wang ME; Tian L; Stepkowski SM; Kahan BD
    Transplant Proc; 1997; 29(1-2):1224-5. PubMed ID: 9123284
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720.
    Chueh SC; Tian L; Wang M; Wang ME; Stepkowski SM; Kahan BD
    Transplantation; 1997 Nov; 64(10):1407-14. PubMed ID: 9392303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of cryptic tolerogenic epitopes in the alpha1-helical region of the RT1.Au alloantigen.
    Wang M; Stepkowski SM; Yu J; Wang M; Kahan BD
    Transplantation; 1997 May; 63(10):1373-9. PubMed ID: 9175796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class I MHC allochimeric presentation of composite immunogenic and self epitopes induces tolerance to genetically diverse rat strains.
    Semiletova NV; Shen XD; Feldman DM; Gao F; Mhoyan A; Liu D; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
    Cell Immunol; 2007 Jul; 248(1):48-58. PubMed ID: 17936255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransplant administration of allochimeric major histocompatibility complex class-I-molecules induces true transplantation tolerance.
    Semiltova N; Shen XD; Fishbein MC; Gao F; Slomowitz SJ; Jiao Q; Mukherjee K; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
    Transplantation; 2003 Feb; 75(4):550-3. PubMed ID: 12605125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of allochimeric proteins to mitigate graft-versus-host and host-versus-graft immune responses to rat small bowel allografts.
    Okamoto M; Stepkowski SM; Wang M; Kahan BD
    Transplantation; 2000 Oct; 70(7):1060-7. PubMed ID: 11045643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance induction by alteration of T cell receptor (TCR) signaling using an allochimeric donor/recipient class I MHC protein.
    Stepkowski SM; Kirken RA; Wang M; Yu J; Akioka K; Kahan BD
    Transplant Proc; 2001; 33(1-2):131. PubMed ID: 11266741
    [No Abstract]   [Full Text] [Related]  

  • 9. Allochimeric class I MHC inhibits chronic rejection in cardiac allografts.
    Singer JS; Shen X; Fishbein M; Mhoyan A; Zhao D; Reemsteen B; Gao F; Amersi F; Coito AJ; Busuttil RW; Weglinski JK; Ghobrial RM
    Transplant Proc; 2001; 33(1-2):179. PubMed ID: 11266768
    [No Abstract]   [Full Text] [Related]  

  • 10. Allochimeric class I MHC molecules prevent chronic rejection and attenuate alloantibody responses.
    Singer JS; Mhoyan A; Fishbein MC; Shen XD; Gao F; Zhao D; Coito AJ; Reemtsen BL; Amersi F; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
    Transplantation; 2001 Oct; 72(8):1408-16. PubMed ID: 11685113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with Escherichia coli-produced soluble MHC class I proteins induces accelerated rejection or prolonged survival of rat cardiac allografts.
    Perez J; Yu J; Stepkowski SM; Kahan BD
    Transplant Proc; 1999 May; 31(3):1560. PubMed ID: 10331000
    [No Abstract]   [Full Text] [Related]  

  • 12. Localization of immunogenic and tolerogenic epitopes in the RT1.A1 alloantigen.
    Wang M; Yu J; Stepkowski SM; Kahan BD
    Transplant Proc; 1999 May; 31(3):1517-8. PubMed ID: 10330987
    [No Abstract]   [Full Text] [Related]  

  • 13. Allochimeric class I MHC protein-induced tolerance by partial TCR engagement requires activation of both CTL4- and common gamma-chain-dependent cytokine signals.
    Stepkowski SM; Kirken RA; Trawick BW; Wang M; Tejpal N; Wang ME; Tian L; Clark J; Kahan BD
    Transplantation; 2002 Apr; 73(8):1227-35. PubMed ID: 11981413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of transplantation tolerance by chimeric donor/recipient class I RT1.Aa molecules.
    Ghobrial RR; Hamashima T; Wang ME; Wang M; Stepkowski SM; Kahan BD
    Transplantation; 1996 Oct; 62(7):1002-10. PubMed ID: 8878396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression.
    Oluwole SF; Jin MX; Chowdhury NC; Ohajekwe OA
    Transplantation; 1994 Nov; 58(10):1077-81. PubMed ID: 7974714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of long-term islet allograft survival in two rat strains by a single allochimeric class I MHC molecule.
    Tanabe Y; Omori K; Hao D; Valiente L; Maruyama M; Smith CV; Weglinski JK; Busuttil RW; Mulen Y; Ghobrial RM
    Transplant Proc; 2001; 33(1-2):157-8. PubMed ID: 11266757
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction of tolerance in rodent cardiac allotransplantation using an MHC class I-derived peptide and cyclosporin A.
    Masroor S; Itescu S; Artrip JH; Minanov OP; Buelow R; Michler RE
    Ann Thorac Surg; 1998 Jan; 65(1):144-8. PubMed ID: 9456108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of NF-AT and NF-kappa B transcription factors in tolerant recipients treated with tolerogenic allochimeric donor/recipient class I MHC protein.
    Akioka K; Kirkin R; Wang M; Tian L; Yu J; Stepkowski SM; Kahan BD
    Transplant Proc; 1999 Nov; 31(7):2745-6. PubMed ID: 10578274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.